Mangoceuticals Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Mangoceuticals Inc 's ROA in the second quarter of 2026?
Mangoceuticals Inc recorded a cumulative net loss of $-15 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -98.65%.

However, within the Healthcare sector 738 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4308, from total ROA ranking in the first quarter of 2026 at 4981.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	-32 %	-33.58 %	4.68 %	11.76 %	36.78 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-15	-19	-21	-20	-14
Return On Assets (TTM)	-98.65 %	-113.13 %	-109.78 %	-106.43 %	-78.09 %
MGRX's Total Ranking	# 4308	# 4981	# 4405	# 4332	# 4325
Total Assets (TTM) in million	14	14	16	17	21
Seq. Total Assets Change	-1.91 %	-10.2 %	-2.67 %	-20.68 %	-4.19 %
Seq. Net Income Change	-	-	-	-	-

MGRX's 5 Years Annual ROA >> Back to MGRX Management Effectiveness >> Compare MGRX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 39
Sector	# 739
Overall	# 4220

Return On Assets Statistics
High	Average	Low
-66.59 %	-173.87 %	-577.75 %
(Mar 31 2025)		(Mar 31 2024)

Financial Statements
Mangoceuticals Inc 's Assets	$ 14 million	MGRX's Balance sheet
Mangoceuticals Inc 's Income	$ -1 million	Quarterly MGRX's Income Statement
MGRX's Income by Division		See MGRX's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	FY	FY
Y / Y Total Assets Change	4.68 %	1362.81 %	-	-	-
Total Assets in million	16	15	1	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-21	-9	-9	0	0
Annual Return On Assets	-128.3 %	-56.65 %	-876.74 %	-	-

MGRX's 5 Years Annual ROA >> Back to MGRX Management Effectiveness >> Compare MGRX ROA to its Competitors

More Return On Assets Ratios
MGRX's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MGRX's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MGRX's Competitors
Subscribers only: Roa for Mangoceuticals Inc 's Suppliers
Subscribers only: Return On Assets for MGRX's Customers

You may also want to know
MGRX's Roi	MGRX's Inventory Turnover Ratio	MGRX's Growth Rates	MGRX's Dividend Comparisons
	MGRX's Profitability Ratios	MGRX's Asset Turnover Ratio	MGRX's Dividend Growth
MGRX's Roe	MGRX's Valuation Ratios	MGRX's Financial Strength Ratios	MGRX's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-02T20:16:47+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.